Loading
Total declarations
Companies
▲ Purchases (13 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Sept 2026 for BriaCell Therapeutics Corp..
Filing timeline
BuySaleJamieson Bondarenko
Insider track record
Disclosed buys
13
Disclosed sells
0
Signal history
Jamieson Bondarenko: trading record in brief
This profile gathers the share dealings of Jamieson Bondarenko across 2 companies, led by BriaCell Therapeutics Corp. and Briapro Therapeutics Corp. In total, 26 filings cover trades dated from 9 February 2019 to 7 July 2026.
Every open-market trade on record is a purchase: 13 purchases worth €189k, and no sale. No amount is published for 10 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 3 share grants and 2 option exercises.
Half of the purchases are above €81k and half below.
The latest filing, published on 24 September 2026, reports a transaction in BriaCell Therapeutics Corp. The last insider purchase was made public on 28 December 2022, 1,396 days ago. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jamieson Bondarenko
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
Performance Share UnitsTSXSEDI:4781139
719,000 sharesRestricted Stock UnitsTSXSEDI:4781103
Restricted Stock UnitsTSXSEDI:4781100
300,000 sharesRestricted Share UnitsTSXSEDI:4748127
300,000 sharesCommon SharesTSXSEDI:4748088
719,000 sharesCommon SharesTSXSEDI:4701061
100,000 sharesRestricted Share UnitsTSXSEDI:4583885
93,333 sharesWarrantsTSXSEDI:4443984
158,532 sharesCommon SharesTSXSEDI:4443998
28,000 shares@ CA$4.5842Common SharesTSXSEDI:4050933
Canonical exit: 28 Mar 2023 (T+90)
22,000 shares@ CA$5.3506Common SharesTSXSEDI:4047749
Canonical exit: 20 Mar 2023 (T+90)
35,836,846 sharesCommon SharesTSXSEDI:3478826
2,142,900 shares@ CA$0.0740.4% of flowCommon SharesTSXSEDI:3439224
3,154,302 shares@ CA$0.0759.6% of flowCommon SharesTSXSEDI:3423960
424,000 sharesCommon SharesTSXSEDI:3382221
Canonical exit: 9 Sept 2019 (T+90)
216,000 sharesCommon SharesTSXSEDI:3370239
Canonical exit: 15 Aug 2019 (T+90)
115,000 sharesCommon SharesTSXSEDI:3368518
Canonical exit: 13 Aug 2019 (T+90)
332,000 sharesCommon SharesTSXSEDI:3368520
Canonical exit: 14 Aug 2019 (T+90)
20,000 sharesCommon SharesTSXSEDI:3367375
Canonical exit: 12 Aug 2019 (T+90)
1,231,000 sharesCommon SharesTSXSEDI:3366738
Canonical exit: 11 Aug 2019 (T+90)
5,000 sharesCommon SharesTSXSEDI:3365327
Canonical exit: 7 Aug 2019 (T+90)
3,000,000 sharesCommon SharesTSXSEDI:3357800
Canonical exit: 17 Jul 2019 (T+90)
200,000 sharesCommon SharesTSXSEDI:3357696
Canonical exit: 16 Jul 2019 (T+90)
250,000 shares@ CA$0.116.7% of flowCommon SharesTSXSEDI:3355728
Canonical exit: 11 Jul 2019 (T+90)
2,000,000 sharesCommon SharesTSXSEDI:3316069
Canonical exit: 13 May 2019 (T+90)
25 of 26 declarations
